Verified Supplement Data Evidence-based supplement comparisons

Statins and Nutrient Depletion: CoQ10, Muscle Pain, and What to Take

By Verified Supplement Data · Published · Methodology · About Us

The short version: Statins block HMG-CoA reductase, the enzyme your body uses to make both cholesterol and CoQ10. They share the same mevalonate pathway. When you lower cholesterol, you also lower CoQ10 — by 16-54% depending on the statin and dose. This CoQ10 depletion is likely responsible for statin myopathy (muscle pain, weakness, fatigue), which affects 10-25% of all statin users and is the number one reason people stop taking statins.

What to take: CoQ10 (ubiquinone) or ubiquinol (the active, reduced form), 100-200mg per day. Two meta-analyses support CoQ10 for reducing statin-associated muscle symptoms. Ubiquinol has higher bioavailability, especially for people over 40.

Are You on a Statin?

Statins are the most prescribed drug class in the United States. Approximately 92 million Americans take a statin. You may be on one without thinking of it as "a statin." Here is every statin currently available:

All statin medications — generic and brand names
Generic NameBrand NameRelative Potency
AtorvastatinLipitorHigh
RosuvastatinCrestorHigh
SimvastatinZocorModerate
PravastatinPravacholLow-Moderate
LovastatinMevacorLow-Moderate
PitavastatinLivaloModerate
FluvastatinLescolLow

All statins share the same mechanism of action — inhibition of HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway. This means all statins deplete CoQ10 to varying degrees. Higher-potency statins (atorvastatin, rosuvastatin) and higher doses cause greater CoQ10 reduction. There is no statin that avoids CoQ10 depletion — it is inherent to how the drug works.

How Statins Deplete CoQ10

To understand why statins deplete CoQ10, you need to understand the mevalonate pathway. This is the same biochemical pathway your body uses to produce both cholesterol and CoQ10:

  1. HMG-CoA is converted to mevalonate by HMG-CoA reductase (the enzyme statins block)
  2. Mevalonate is converted through several steps to farnesyl pyrophosphate (FPP)
  3. FPP branches into two directions:
    • Cholesterol synthesis (the target statins are trying to reduce)
    • CoQ10 synthesis (collateral depletion — not the target, but unavoidable)

Statins block the pathway upstream of the branch point. They cannot selectively reduce cholesterol without also reducing CoQ10. This is not a side effect — it is a direct pharmacological consequence of the drug's mechanism of action. Every molecule of HMG-CoA reductase that a statin disables is one less molecule available for both cholesterol and CoQ10 production.

The result: statin users show 16-54% reductions in plasma CoQ10 levels, depending on the statin, dose, and study population.

Nutrient Depletion Table

Nutrients depleted by statin medications
Nutrient Mechanism Evidence Level Clinical Impact What to Take
CoQ10 (Ubiquinone) Same mevalonate pathway — statins block upstream of CoQ10 synthesis Strong (biochemically established, multiple meta-analyses) Muscle pain/weakness (10-25% of users), fatigue, exercise intolerance CoQ10 or ubiquinol, 100-200mg/day
Vitamin D 7-dehydrocholesterol (D3 precursor) is a cholesterol pathway intermediate Mixed (plausible mechanism, conflicting observational data) Unclear — may contribute to muscle symptoms, bone health concerns Vitamin D3, 1000-2000 IU/day (broadly recommended regardless)

Statin Myopathy: The Number One Problem

Statin-associated muscle symptoms (SAMS), commonly called statin myopathy, affect 10-25% of statin users depending on the study and definition used. Symptoms range from mild muscle aching to severe weakness and, in rare cases (< 0.1%), rhabdomyolysis (muscle breakdown). The spectrum includes:

  • Myalgia: Muscle pain or soreness without elevated CK levels (most common)
  • Myopathy: Muscle weakness with elevated CK levels
  • Fatigue and exercise intolerance: Reduced exercise capacity, feeling "heavy" during workouts
  • Rhabdomyolysis: Severe muscle breakdown with CK > 10x upper limit of normal (rare but dangerous)

Statin myopathy is the number one reason patients discontinue statin therapy. This is clinically significant because statins are proven to reduce cardiovascular events and mortality. When patients stop statins due to muscle pain, they lose the cardiovascular protection. This makes managing statin myopathy — rather than simply stopping the drug — a priority.

The connection between CoQ10 depletion and muscle symptoms is biologically plausible: CoQ10 is essential for mitochondrial energy production in the electron transport chain. Muscle tissue has high mitochondrial density and high energy demands. When CoQ10 levels drop, mitochondrial function in muscle tissue is impaired, leading to pain, weakness, and fatigue.

The Evidence: CoQ10 for Statin Muscle Pain

Two key meta-analyses address whether CoQ10 supplementation helps with statin-associated muscle symptoms:

Banach 2015 — Meta-analysis of CoQ10 for Statin Myopathy

PMID: 26234654. This meta-analysis of randomized controlled trials found that CoQ10 supplementation significantly decreased statin-associated muscle symptoms, including pain severity, compared to placebo. The effect was most pronounced in patients who had documented CoQ10 depletion.

Qu 2018 — Meta-analysis of CoQ10 + Statin Muscle Pain

PMID: 29562092. This updated meta-analysis confirmed that CoQ10 supplementation reduced muscle pain scores in statin users. The analysis also noted improvements in muscle weakness scores, though with greater heterogeneity between studies.

Taylor 2015 — GOAL Trial (The Best Negative Study)

PMID: 25545331. This was the most rigorously designed trial: 120 patients screened, blinded crossover to confirm genuine statin myopathy. CoQ10 600mg/day (ubiquinol) vs placebo. Result: no benefit. Critically, only 36% of patients who reported statin muscle pain actually developed symptoms when blinded — suggesting most "statin muscle pain" may be nocebo effect.

Amin 2025 — Most Recent Positive Meta-Analysis

PMID: 41158831. The most recent meta-analysis (7 RCTs, n=389) found CoQ10 supplementation produced a statistically significant reduction in pain intensity vs placebo.

Our Honest Assessment

Three of four meta-analyses show benefit. The best individual RCT was negative. The weight of evidence leans positive, but it's not definitive. Interestingly, the negative GOAL trial used 600mg/day — the highest dose studied — while positive trials used 100-200mg/day, suggesting higher doses may not be better.

No major cardiology guideline (AHA/ACC, ESC, NLA) formally recommends CoQ10 for statin users. The NLA acknowledges the evidence and states "there are no known risks to this supplement." At $0.32/day for 200mg, the cost-to-risk ratio favors trying it if you have genuine statin muscle symptoms.

Notable Regulatory Gap

The FDA has not issued a formal safety communication about CoQ10 depletion from statins. In 2014, the FDA rejected a citizen petition requesting mandatory CoQ10 labeling on statin packaging. This is in contrast to the FDA's 2010 and 2011 warnings about PPI-induced fractures and hypomagnesemia. Health Canada and some European health authorities acknowledge CoQ10 depletion in statin literature, but the US FDA has not followed suit. The biochemistry is well-established regardless of regulatory recognition.

Ubiquinol vs Ubiquinone: Which Form to Take

CoQ10 supplements come in two forms, and the distinction matters — especially for statin users over 40:

Ubiquinol (reduced) vs ubiquinone (oxidized) CoQ10 — comparison
Property Ubiquinone (Oxidized) Ubiquinol (Reduced)
What it is Conventional CoQ10 supplement form Active, electron-rich form your body uses
Body conversion Must be converted to ubiquinol to function Already in active form — no conversion needed
Bioavailability Lower — requires intestinal conversion 3-8x higher absorption in studies
Age factor Conversion efficiency declines after age 40 Bypasses age-related conversion decline
Cost $0.15-0.45/day at 200mg $0.65-1.40/day at 200mg
Best for Under 40, budget-conscious, general supplementation Over 40, statin users, documented CoQ10 deficiency
Look for BioPerine for enhanced absorption; take with fat-containing meal Kaneka QH (dominant quality supplier)

For statin users specifically: Ubiquinol is the preferred form if you are over 40 or experiencing muscle symptoms. Your body's ability to convert ubiquinone to ubiquinol is already reduced by age, and statin use further stresses the pathway. Ubiquinol skips the conversion step entirely and delivers the active form directly. The tradeoff is cost — ubiquinol is 2-3x more expensive per dose.

If you are under 40 and cost-conscious, ubiquinone with BioPerine (black pepper extract, which enhances absorption) is a reasonable alternative. Take it with a fat-containing meal to maximize absorption, as CoQ10 is fat-soluble.

CoQ10 Product Comparison

All products evaluated at 200mg/day — the upper end of the clinical dose range for statin users. Products are sorted by cost per day.

CoQ10 and ubiquinol supplements — cost, form, and certification comparison
Product Form Per Serving Serving Size Servings Price Cost/Day (200mg) Pick
Doctor's Best High Absorption CoQ10 200mg with BioPerine Ubiquinone 200mg 1 veggie capsule 60 $18.99 $0.32 Budget
Qunol Ultra CoQ10 100mg (Water & Fat Soluble) Ubiquinone 100mg 1 softgel 120 $25.48 $0.42 Best Value
Jarrow Formulas QH-Absorb Ubiquinol 100mg Ubiquinol 100mg 1 softgel 120 $39.95 $0.67 Quality
NOW Foods Ubiquinol 200mg Extra Strength Ubiquinol 200mg 1 softgel 60 $46.99 $0.78
Life Extension Super Ubiquinol CoQ10 with Enhanced Mitochondrial Support 100mg Ubiquinol 100mg 1 softgel 60 $42.00 $1.40

Our Picks

  • Budget Pick — Doctor's Best CoQ10 200mg with BioPerine: Lowest cost per day at $0.32. This is ubiquinone (not ubiquinol), but the BioPerine enhances absorption. One capsule delivers the full 200mg clinical dose. Naturally fermented. Best for: under 40, cost-conscious, or trying CoQ10 for the first time.
  • Best Value — Qunol Ultra CoQ10 100mg: Patented water and fat soluble formula claims 3x better absorption than standard CoQ10. 120 softgels is a 60-day supply at 200mg/day. At $0.42/day, it sits in the sweet spot between budget ubiquinone and premium ubiquinol.
  • Quality Pick — Jarrow QH-Absorb Ubiquinol 100mg: Ubiquinol (active form) with Kaneka QH and proprietary proliposome delivery technology. Clinically shown to increase CoQ10 levels 222% over baseline. Best for: over 40, active muscle symptoms, or documented CoQ10 depletion. 120 softgels at $0.67/day.

Vitamin D and Statins — Myth vs Reality

Statins do NOT deplete vitamin D. This is widely claimed on supplement sites, but the evidence shows the opposite — some statins actually increase vitamin D levels by competing for the CYP3A4 enzyme that breaks down vitamin D (rosuvastatin raised 25(OH)D from 11.8 to 35.2 ng/mL in one study).

However, low vitamin D is independently associated with higher risk of statin muscle symptoms (Jetty et al., PMID: 29067242 — 77% sensitivity for predicting SAMS). Since 42% of Americans are already deficient regardless of statin use, checking your level is reasonable.

But the definitive test was negative: The VITAL trial substudy randomized ~2,000 new statin users to vitamin D 2,000 IU/day vs placebo. Result: vitamin D did NOT prevent statin muscle symptoms (31% vs 31%, OR 0.97) — even in patients with baseline 25(OH)D below 20 ng/mL (Hsia et al. 2022, PMID: 36416841).

Our recommendation: Fix vitamin D deficiency for the many other health benefits (bone, immune, mood) — not specifically for statin muscle pain. See our vitamin D supplement guide.

Dosing Protocol for Statin Users

Recommended supplementation protocol for statin users
SupplementDoseWhen to TakePriority
CoQ10 or Ubiquinol 100-200mg/day With a fat-containing meal (breakfast or dinner). Split into 2 doses if taking 200mg ubiquinone. High — especially if experiencing muscle symptoms
Vitamin D3 1000-2000 IU/day With a fat-containing meal (fat-soluble vitamin) Moderate — broadly recommended regardless of statin use

Timing note: CoQ10 does not interfere with statin absorption or efficacy. You can take them at the same time. Some patients prefer to take their statin at night and CoQ10 in the morning — either approach is fine.

Frequently Asked Questions

Do statins deplete CoQ10?

Yes. Statins inhibit HMG-CoA reductase, the same enzyme that produces CoQ10 in the body. Both cholesterol and CoQ10 share the mevalonate biosynthetic pathway. Statin use has been shown to reduce plasma CoQ10 levels by 16-54% depending on the statin, dose, and duration. This is a direct pharmacological effect, not a side effect — it is inherent to the mechanism of action of all statins.

Should I take CoQ10 if I'm on a statin?

If you are experiencing statin-related muscle pain (statin myopathy), CoQ10 supplementation at 100-200mg per day is a reasonable intervention supported by multiple meta-analyses. A 2015 meta-analysis by Banach et al. (PMID: 26234654) found that CoQ10 significantly decreased statin-associated muscle symptoms. Even if you are not experiencing symptoms, some clinicians recommend prophylactic CoQ10 supplementation for statin users, though this is not yet standard of care. Discuss with your prescribing physician.

What is the difference between ubiquinol and ubiquinone?

Ubiquinone (oxidized CoQ10) is the conventional supplement form. Ubiquinol (reduced CoQ10) is the active, electron-rich form your body actually uses. Your body converts ubiquinone to ubiquinol, but this conversion becomes less efficient with age, especially after 40. Ubiquinol has 3-8x higher bioavailability in studies. For statin users over 40, ubiquinol may be the better choice despite higher cost, because the conversion pathway is already stressed by statin use.

Do statins deplete vitamin D?

The evidence is mixed. There is a plausible mechanism (vitamin D synthesis involves the mevalonate/cholesterol pathway), but observational data is conflicting — some studies show lower vitamin D levels in statin users, others show no effect or even increases. Regardless, vitamin D deficiency is extremely common (42% of US adults), and 1000-2000 IU D3 daily is broadly recommended. If you are on a statin, monitoring vitamin D levels is reasonable.

Has the FDA issued a warning about CoQ10 depletion from statins?

No. Unlike the FDA warnings issued for PPIs (fracture risk in 2010, hypomagnesemia in 2011), the FDA has not issued a formal safety communication about statin-induced CoQ10 depletion. In 2014, the FDA rejected a citizen petition requesting mandatory CoQ10 labeling on statin packaging. Health Canada and some European health authorities acknowledge CoQ10 depletion in statin literature, but the US FDA has not followed suit. The biochemistry is well-established regardless of regulatory recognition.

Related Guides

Medication-Nutrient Depletion

Related Supplement Guides

Sources

  1. Banach M, Serban C, Sahebkar A, et al. Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. Mayo Clin Proc. 2015;90(1):24-34. CoQ10 significantly decreased statin-associated muscle symptoms. PMID: 26234654
  2. Qu H, Guo M, Chai H, et al. Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7(19):e009835. Updated meta-analysis confirming CoQ10 reduces statin-related muscle pain scores. PMID: 29562092
  3. Marcoff L, Thompson PD. The role of coenzyme Q10 in statin-associated myopathy: a systematic review. J Am Coll Cardiol. 2007;49(23):2231-2237. Systematic review of CoQ10 depletion by statins. PMID: 17560286
  4. Littlefield N, Beckstrand RL, Luthy KE. Statins' effect on plasma levels of coenzyme Q10 and improvement in myopathy with supplementation. J Am Assoc Nurse Pract. 2014;26(2):85-90. Review of statin-CoQ10 relationship and supplementation outcomes. PMID: 24170654
  5. Stroes ES, Thompson PD, Corsini A, et al. Statin-associated muscle symptoms: impact on statin therapy — European Atherosclerosis Society consensus panel statement. Eur Heart J. 2015;36(17):1012-1022. 10-25% prevalence of statin-associated muscle symptoms. PMID: 25694464
  6. Skarlovnik A, Janic M, Germ D, et al. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study. Med Sci Monit. 2014;20:2183-2188. RCT showing CoQ10 reduced statin myopathy symptoms. PMID: 25375075
  7. Taylor BA, et al. "A randomized trial of CoQ10 in patients with confirmed statin myopathy." Atherosclerosis. 2015;238(2):329-335. GOAL trial: 600mg/day ubiquinol, no benefit; only 36% had genuine myopathy in blinded crossover. PMID: 25545331
  8. Amin F, et al. "CoQ10 supplementation and statin-associated muscle symptoms: meta-analysis of 7 RCTs, n=389." J Nutr Sci. 2025. Significant reduction in pain intensity. PMID: 41158831
  9. Qu H, et al. "Effect of statin treatment on circulating CoQ10: meta-analysis of 12 RCTs, n=1,776." Eur J Med Res. 2018;23(1):57. SMD -2.12 (P=0.001). PMID: 30414615
  10. Hsia J, et al. "Effect of vitamin D supplementation on statin-associated muscle symptoms." JAMA Cardiol. 2022;7(12):1218-1226. VITAL substudy: vitamin D did NOT prevent SAMS (31% vs 31%). PMID: 36416841
  11. Jetty V, et al. "Assessment of vitamin D and statin-related myalgia." J Clin Med Res. 2016. Low 25(OH)D: 77% sensitivity for SAMS. PMID: 29067242
  12. Salami JA, et al. "National trends in statin use: 92 million Americans as of 2018-2019." PMC10093150.
  13. U.S. Food and Drug Administration. Citizen Petition Response: CoQ10 labeling on statin packaging. 2014. FDA denied the petition requesting mandatory CoQ10 depletion warning labels on statin medications.